Driving Value from Tax: Cash Incentives Available to Texas Life Sciences Companies
11:00 am – 12:00 pm
September 8, 2022
Join us to learn about Federal and State incentives available for companies in the life sciences industry.
11:00 am – 12:00 pm
September 8, 2022
Join us to learn about Federal and State incentives available for companies in the life sciences industry.
12:00 pm – 1:00 pm
September 14, 2022
NASA’s Lessons Learned Program was designed to educate new generations of NASA engineers on mistakes of the past in order to prevent future accidents, a lesson that can be taken to heart across industries involving teamwork by highly specialized teams.
All day
September 21, 2022 – September 23, 2022
The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare.
11:00 am – 12:00 pm
September 21, 2022
The fair offers employers a great opportunity to meet diverse undergraduate and graduate students from all majors, promote your open positions, and build your brand with UT Austin students.
All day
September 21, 2022 – September 23, 2022
The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare.
10:00 am – 11:00 am
September 22, 2022
During this webinar, NAMSA’s Principal IVD Biostatistician will examine the benefits of including biostatistics early and often in a clinical trial, provide insight on how to prevent unnecessary delays and walk through two real-world case studies.
All day
September 21, 2022 – September 23, 2022
The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare.
8:00 am – 9:00 am
September 30, 2022
Virtual worlds help bridge the gap until the next time you can see a person in real life. We’ll explore the moments that matter and and why this is so important. More information at tagaustin.org